Related Experiment Video
Updated: Aug 12, 2026

Candida albicans Biofilm Chip (CaBChip) for High-throughput Antifungal Drug Screening
Published on: July 18, 2012
The uptake of fluconazole in finger and toe nails
H Laufen1, T Zimmermann, R A Yeates
1Pfizer Pharmaceutical Group R & D Illertissen, Germany.
Objective:
The uptake of the antimycotic agent fluconazole in finger and toe nail following various treatment schedules was investigated in order to characterize the pharmacokinetic basis for the systemic treatment of onychomycosis with fluconazole.
Subjects:
Between 8 and 12 healthy, male and female Caucasian subjects were included in four separate studies. Mean age of the subjects in the single studies ranged between 34 years (study 4, group 2; n = 4 male and 4 female) and 38 years (study 4, group 1; n = 4 male and 4 female).
Methods:
Fluconazole was administered orally over 4 weeks in all studies. The treatment schedules were 150 mg once weekly (study 1), 300 mg once weekly (study 2), 50 mg once daily (study 3) and 150 or 300 mg once weekly in a parallel group study (study 4). At fixed times samples of blood, nail cuttings and nail dust were taken, up to two months after end of treatment. Fluconazole was analyzed in blood plasma and in the nail samples using a highly specific and sensitive gas chromatographic procedure.
Results:
High concentrations of fluconazole were found in distal nail clippings with all three treatments. Mean maximum concentrations which occurred in the third or fourth week of treatment amounted to 2.1 microg/g (150 mg/w), 5.4 microg/g (300 mg/w) and 6.5 microg/g (50 mg/d) in finger nails and to 9.6 microg/g (150 mg/w), 12.3 microg/g (300 mg/w) and 12.2 microg/g (50 mg/d) in toe nails. The nail concentrations were 1-2 times (finger) and 2-3 times (toe) higher than the corresponding fluconazole plasma levels and were within the MIC range for dermatophytes and yeasts occurring commonly in onychomycosis. The residence times of fluconazole in the nail plate after the end of treatment was long, with approximate half-lives of 33 days in finger nail and 30 days in toe nail. In pharmacokinetic terms there was no evidence of advantages of the daily dosage (50 mg) over the once-weekly (300 mg) dosage. Fluconazole was found to penetrate into both finger and toe nails at a very fast rate. On the first two days of the 150 mg/w and 300 mg/w treatments, i.e. after the first dosage, fluconazole concentrations in the distal nail plates amounted to 50-80% of the later observed peak levels. The initial concentrations in the upper dorsal plate were particularly high, with mean peak concentrations of 11.9 microg/g (150 mg) and 33.7 microg/g (300 mg) in finger nails and 5.7 microg/g (150 mg) and 24.4 microg/g (300 mg) in toe nails.
Conclusions:
Fluconazole is rapidly and highly distributed into finger and foot nail, reaching there higher concentrations than in the plasma. The rapid initial uptake of fluconazole in nail, which is unlike the uptake of other antifungal agents, suggests the existence of special routes of access to the nail for fluconazole, possibly based on high diffusion rates.
Insights
Fluconazole rapidly penetrates nails, achieving high concentrations for treating fungal infections. Weekly or daily dosing shows similar effectiveness, with long-lasting drug presence in nails.
Area of Science:
- Pharmacology
- Dermatology
- Mycology
Background:
- Onychomycosis (fungal nail infection) treatment requires effective antifungal drug delivery to the nail plate.
- Understanding the pharmacokinetics of antifungal agents like fluconazole is crucial for optimizing treatment strategies.
Purpose of the Study:
- To investigate fluconazole uptake in fingernails and toenails under different oral treatment schedules.
- To characterize the pharmacokinetic basis for systemic fluconazole treatment of onychomycosis.
Main Methods:
- Four studies involving 8-12 healthy adults each, receiving oral fluconazole over 4 weeks.
- Treatment schedules included weekly (150mg, 300mg) and daily (50mg) dosing.
- Blood, nail clippings, and dust samples were collected up to two months post-treatment and analyzed using gas chromatography.
Main Results:
- High fluconazole concentrations were achieved in both finger and toenails, exceeding plasma levels.
- Nail concentrations were within the minimum inhibitory concentration (MIC) range for common onychomycosis pathogens.
- Fluconazole demonstrated rapid nail penetration and long residence times (half-lives of ~30-33 days).
- No significant pharmacokinetic advantage of daily over weekly dosing was observed.
Conclusions:
- Fluconazole is rapidly and highly distributed into nails, achieving concentrations superior to plasma.
- The unique, rapid uptake suggests specialized routes of entry into the nail for fluconazole.
- Findings support fluconazole's potential as an effective systemic treatment for onychomycosis.

